Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB26FWQTS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,071
Award facts
- Contract value 100% obligated
- $10,071.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,071.36 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for RINVOQ ER 15 mg tablets (30-count units), with completion scheduled for October 24, 2025. This firm fixed-price contract represents a non-competitive delivery order, with performance occurring at the contractor's Conshohocken, Pennsylvania facility. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as the comprehensive global pharmaceutical supply vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant role in the federal medical supply chain as a critical vendor for Defense Health Agency and military healthcare systems. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical commodities to support military operations and healthcare delivery worldwide. This particular delivery order for RINVOQ, a specialty rheumatologic medication, exemplifies the company's role in fulfilling specific pharmaceutical needs across the Defense Logistics Agency's extensive medical supply requirements. All reviewed contract awards with AmerisourceBergen demonstrate competitive procurement practices with firm fixed pricing structures, reflecting the contractor's established capability to meet federal pharmaceutical procurement standards.
Quick answers
Who was awarded contract SPE2DB26FWQTS?
SPE2DB26FWQTS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FWQTS worth?
The government has obligated $10,071 on SPE2DB26FWQTS.
Is contract SPE2DB26FWQTS an order under another contract?
Yes. SPE2DB26FWQTS is a delivery order under SPE2DB25D3007, an indefinite delivery contract.
Was contract SPE2DB26FWQTS competed?
The extent of competition for SPE2DB26FWQTS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award